JNK1/3 Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-62902r-100uL |
| Product Name | JNK1/3 Recombinant Antibody |
| Applications |
WB
IHC-P
IHC-F
IF(IHC-P)
IP
|
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human JNK1 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 5599 |
| Swiss Prot | P45983,P53779 |
| Synonyms | c-Jun N-terminal kinase 3; FLJ12099; FLJ33785; JNK1; JNK3; JNK3 alpha protein kinase; JNK3A; MAP kinase 10; MAP kinase p49 3F12; MAPK 10; MAPK10. |
| Background | Serine/threonine-protein kinase involved in various processes such as cell proliferation, differentiation, migration, transformation and programmed cell death. Extracellular stimuli such as pro-inflammatory cytokines or physical stress stimulate the stress-activated protein kinase/c-Jun N-terminal kinase (SAP/JNK) signaling pathway. |
| Application Dilution | |
| WB | IP1:20-50 |
| IHC-P | IHC-F1:100-500 |
| IHC-F | IHC-P1:100-500 |
| IF(IHC-P) | WB1:500-2000 |
| IP | IFIHC-P1:100-500 |
Frequently asked questions
Which applications is JNK1/3 Recombinant Antibody (bsm-62902R) validated for, and at what dilution?
bsm-62902R is validated for WB(IP) (1:20-50); IHC-P(IHC-F) (1:100-500); IHC-F(IHC-P) (1:100-500); IF(IHC-P)(WB) (1:500-2000); IP(IF(IHC-P)) (1:100-500). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does JNK1/3 Recombinant Antibody (bsm-62902R) react with?
Tested reactivity: Human, Mouse, Rat.
How should bsm-62902R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise JNK1/3 Recombinant Antibody (bsm-62902R)?
KLH conjugated synthetic peptide derived from human JNK1